BlackRock Group’s BioMarin Pharmaceuticals BMRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
$90.4M Buy
1,091,545
+51,530
+5% +$4.43M 0.04% 456
2016
Q3
$96.2M Buy
1,040,015
+16,645
+2% +$1.57M 0.05% 425
2016
Q2
$79.6M Sell
1,023,370
-77,394
-7% -$6.58M 0.04% 460
2016
Q1
$90.8M Sell
1,100,764
-385
-0% -$31.3K 0.05% 411
2015
Q4
$115M Buy
1,101,149
+34,211
+3% +$3.57M 0.06% 348
2015
Q3
$112M Sell
1,066,938
-8,498
-0.8% -$1.14M 0.07% 333
2015
Q2
$147M Sell
1,075,436
-92,586
-8% -$11.5M 0.08% 282
2015
Q1
$146M Sell
1,168,022
-54,128
-4% -$5.74M 0.08% 295
2014
Q4
$110M Sell
1,222,150
-43,489
-3% -$3.62M 0.06% 365
2014
Q3
$91.3M Buy
1,265,639
+105,888
+9% +$6.96M 0.05% 406
2014
Q2
$72.1M Sell
1,159,751
-119,889
-9% -$7.24M 0.04% 466
2014
Q1
$87.3M Buy
1,279,640
+544,559
+74% +$40.1M 0.05% 391
2013
Q4
$51.7M Buy
735,081
+21,923
+3% +$1.49M 0.03% 534
2013
Q3
$51.5M Buy
713,158
+228,100
+47% +$15.2M 0.03% 529
2013
Q2
$27M Buy
+485,058
New +$30.2M 0.02% 644

Other funds holding BMRN